BCBA/ABT (BCBA/ABT)

Buenos Aires Stock Exchange: BCBA/ABT · ARS

ARS 42,340

-1558.39 (-3.5%)· Recorded snapshot

Market cap	274.4T
Revenue (ttm)	73.5T
Net income (ttm)	7.1T
EPS (ttm)	ARS 1,034
P/E (trailing)	40.9x
P/E (forward)	17.5x
Dividend	ARS 666 (1.57%)
Volume	1,026

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 73.5T
Net income (ttm): 7.1T
EPS (ttm): ARS 1,034
P/E (trailing): 40.9x
P/E (forward): 17.5x
Market cap: 274.4T

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E17.5

P25 n/aP50 n/aP75 n/a

Trailing P/E40.9

P25 n/aP50 n/aP75 n/a

ROE10.6

P25 n/aP50 n/aP75 n/a

ROIC7.2

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

S&P 500+0.8%

Nasdaq Composite-1.0%

Dow Jones Industrial Average+1.9%

Russell 2000+0.3%

All BCBA/ABT indicators

Market & fundamental data

Available fields

241

Groups with data

Currency

USD

Showing 241 of 241 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	ARS
Country	United States
Country code	AR
Earnings date	2026-10-21
Employees	122,000
Employees change	7,000
Employees growth	6.09%
Enterprise value	ARS 317.1T
Exchange	Buenos Aires Stock Exchange
Financial currency	USD
Financial report date	2026-09-30
First seen	2026-05-10
Fiscal year end	December
Founded	1888
Industry	Medical Devices
Is primary listing	No
ISIN number	ARDEUT110608
Last earnings date	2026-10-21
Last refreshed	2026-10-28
Last stock split date	2020-10-22
Last stock split type	Forward
Market cap	ARS 274.4T
Price	ARS 42,340.00
Price currency	ARS
Sector	Healthcare
SIC code	3845
Stock price date	2026-10-27
Symbol	bcba/ABT
Website	https://www.abbott.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	50.21x
Average P/E ratio (3Y)	27.41x
Average P/E ratio (5Y)	28.1x
Earnings yield	2.44%
EV/Earnings	44.47x
EV/EBIT	25.83x
EV/EBITDA	16.7x
EV/FCF	26.36x
EV/Sales	4.27x
FCF / EV yield	3.79%
FCF yield	4.38%
Forward P/E	17.55x
Graham number	17364.36475
Graham upside	-58.99%
Lynch fair value	ARS 5,501.94
Lynch upside	-87.01%
P/(FCF - SBC) ratio	25.12x
P/(OCF - SBC) ratio	19.43x
P/B ratio	3.48x
P/E ratio	40.94x
P/FCF ratio	22.81x
P/OCF ratio	18.02x
P/S ratio	3.73x
Price/EBITDA ratio	15.05x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	16.55%
EBITDA margin	24.79%
Effective tax rate	28.36%
FCF margin	16.8%
Gross margin	57.08%
Operating margin	16.55%
Pretax margin	13.61%
Profit margin	9.75%
Profit per employee	ARS 62M
Profitable quarters	34
Profitable years	35
Revenue per employee	ARS 639.5M
ROA	5.33%
ROA (5Y)	6.84%
ROCE	9.01%
ROE	10.58%
ROE (5Y)	19.7%
ROIC	7.25%
ROIC (5Y)	14.92%
SBC / revenue	1.54%
Tax / revenue	3.86%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-66.24%
EPS growth (Q)	-43.69%
EPS growth (QoQ)	-0.12%
EPS growth 10Y	11.38%
EPS growth 3Y	-2.87%
EPS growth 5Y	-7.76%
EPS growth years	0
FCF growth	15.48%
FCF growth 3Y	12.55%
FCF growth 5Y	-1.97%
Gross profit growth	12.07%
Gross profit growth (Q)	17.95%
Gross profit growth 3Y	7.75%
Gross profit growth 5Y	2.62%
Net income growth	-66.37%
Net income growth (Q)	-44.04%
Net income growth (QoQ)	-0.86%
Net income growth 3Y	-3.11%
Net income growth 5Y	-8.3%
Net income growth years	0
OCF growth	9.61%
OCF growth 10Y	13.31%
OCF growth 3Y	9.95%
OCF growth 5Y	-1.4%
Operating income growth	-5.19%
Operating income growth (Q)	-33.06%
Operating income growth 3Y	5.37%
Operating income growth 5Y	-2.23%
Revenue growth	10%
Revenue growth (Q)	14.46%
Revenue growth (QoQ)	3.34%
Revenue growth 10Y	8.82%
Revenue growth 3Y	6.47%
Revenue growth 5Y	2.65%
Revenue growth quarters	11
Revenue growth years	2

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	ARS -3.2T
Depreciation and amortization	ARS 6.1T
EBIT	ARS 12.2T
EBITDA	ARS 18.2T
EPS	ARS 1,034.24
Financing cash flow	ARS 16.4T
Free cash flow	ARS 12T
Free cash flow minus SBC	ARS 10.9T
Gross profit	ARS 42T
Income taxes	ARS 2.8T
Investing cash flow	ARS -34.4T
Net borrowing	ARS 25.4T
Net cash flow	ARS -2.8T
Net income	ARS 7.1T
Operating cash flow minus SBC	ARS 14.1T
Operating income	ARS 12.2T
Revenue	ARS 73.5T
Stock-based compensation	ARS 1.1T

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	ARS 45,040.68
Debt / EBITDA	2.65
Debt / equity	0.63
Debt / FCF	4.15
Interest coverage	7.87
Net cash (debt)	ARS -41.4T
Net cash / market cap	-15.07%
Net debt / EBITDA	2.27
Net debt / equity	0.52
Net debt / FCF	3.44
Piotroski F-Score	5
Shareholders' equity	ARS 78.9T
Tangible book value	ARS -2.1T
Tangible book value per share	ARS -1,185.28
Total cash	ARS 8.5T
Total debt	ARS 49.9T

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.48
Current ratio	1.38
Inventory turnover	2.82
Quick ratio	0.8
Working capital	ARS 10.3T

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.25%
Dividend growth	47.34%
Dividend growth (10Y)	76.1%
Dividend growth (3Y)	89.59%
Dividend growth (5Y)	91.48%
Dividend growth years	12
Dividend payment date	2026-11-16
Dividend payment years	27
Dividend payout frequency	Quarterly
Dividend per share	ARS 666.10
Dividend yield	1.57%
Ex-dividend date	2026-10-15
Last dividend	ARS 238.47
Payout ratio	64.27%
Shareholder yield	1.82%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	27,769.01%
10Y return CAGR	77.42%
10Y total return	30,774.38%
150-day SMA	ARS 38,296.00
15Y price change	65,773.2%
15Y return CAGR	55.78%
15Y total return	77,109.56%
1D price change	-3.55%
1M price change	3.42%
1M total return	4.02%
1W price change	0.43%
1W total return	0.43%
1Y price change	-14.5%
1Y return CAGR	-13.07%
1Y total return	-13.06%
20-day SMA	ARS 41,193.00
200-day SMA	ARS 39,350.60
20Y price change	113,870.39%
20Y return CAGR	43.46%
20Y total return	136,285.64%
3M price change	2.82%
3M total return	3.41%
3Y price change	103.56%
3Y return CAGR	28.3%
3Y total return	111.23%
50-day SMA	ARS 42,232.00
50-day SMA vs 200-day SMA	50over200
52-week high	ARS 52,000.00
52-week high date	2025-10-27
52-week low	ARS 30,380.00
52-week low date	2026-05-11
5Y price change	556.43%
5Y return CAGR	47.13%
5Y total return	589.3%
6M price change	24.09%
6M total return	25.34%
All-time high	ARS 53,525.00
All-time high date	2025-09-19
All-time low	ARS 10.55
All-time low date	2000-09-12
Average true range (ATR)	ARS 1,187.19
Average volume	2.2K
Change from 52-week high	-18.58%
Change from 52-week low	39.37%
Change from all-time high	-20.9%
Change from all-time low	401,227.01%
Change from open	-1.81%
Day's gap	-1.78%
Dollar volume	ARS 43.4M
High price	ARS 43,200.00
Low price	ARS 41,800.00
Monthly RSI	55.36
Open price	ARS 43,120.00
Position in 52-week range	38.57%
Previous close	ARS 43,900.00
Price vs 150-day SMA	10.56%
Price vs 20-day SMA	2.78%
Price vs 200-day SMA	7.6%
Price vs 50-day SMA	0.26%
Relative volume	0.47
RSI	53.93
Sharpe ratio	-0.27
Sharpe ratio (3Y)	0.86
Sharpe ratio (5Y)	1.22
Sortino ratio	-0.2
Sortino ratio (3Y)	1.45
Sortino ratio (5Y)	2.04
Volume	1K
Weekly RSI	55.03
YTD price change	-11.39%
YTD total return	-9.89%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1.7B
Shares change (QoQ)	-0.29%
Shares change (YoY)	-0.25%
Shares held by insiders	0.5%
Shares held by institutions	80.99%
Short ratio	1.9 days

Deeper analysis on BCBA/ABT

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Scorecard

Six-factor overlay and 9-category weighted scorecard.

→

Recommendation

Final action, action steps, opportunity, and biggest risk.

→

Perspectives

Growth, value, and income investor reads.

→

Frequently asked questions

About this BCBA/ABT report

Is a complete BCBA/ABT research report available?

No complete published report is available for bcba/ABT (BCBA/ABT) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Market cap

274.4T

Revenue (ttm)

73.5T

Net income (ttm)

7.1T

EPS (ttm)

ARS 1,034

P/E (trailing)

40.9x

P/E (forward)

17.5x

Dividend

ARS 666 (1.57%)

Volume

1,026

Metric

Value

Amount currency

ARS

Country

United States

Country code

Earnings date

2026-10-21

Employees

122,000

Employees change

7,000

Employees growth

6.09%

Enterprise value

ARS 317.1T

Exchange

Buenos Aires Stock Exchange

Financial currency

USD

Financial report date

2026-09-30

First seen

2026-05-10

Fiscal year end

December

Founded

1888

Industry

Medical Devices

Is primary listing

ISIN number

ARDEUT110608

Last earnings date

2026-10-21

Last refreshed

2026-10-28

Last stock split date

2020-10-22

Last stock split type

Forward

Market cap

ARS 274.4T

Price

ARS 42,340.00

Price currency

ARS

Sector

Healthcare

SIC code

3845

Stock price date

2026-10-27

Symbol

bcba/ABT

Website

https://www.abbott.com

Metric

Value

Average P/E ratio (10Y)

50.21x

Average P/E ratio (3Y)

27.41x

Average P/E ratio (5Y)

28.1x

Earnings yield

2.44%

EV/Earnings

44.47x

EV/EBIT

25.83x

EV/EBITDA

16.7x

EV/FCF

26.36x

EV/Sales

4.27x

FCF / EV yield

3.79%

FCF yield

4.38%

Forward P/E

17.55x

Graham number

17364.36475

Graham upside

-58.99%

Lynch fair value

ARS 5,501.94

Lynch upside

-87.01%

P/(FCF - SBC) ratio

25.12x

P/(OCF - SBC) ratio

19.43x

P/B ratio

3.48x

P/E ratio

40.94x

P/FCF ratio

22.81x

P/OCF ratio

18.02x

P/S ratio

3.73x

Price/EBITDA ratio

15.05x

Metric

Value

EBIT margin

16.55%

EBITDA margin

24.79%

Effective tax rate

28.36%

FCF margin

16.8%

Gross margin

57.08%

Operating margin

16.55%

Pretax margin

13.61%

Profit margin

9.75%

Profit per employee

ARS 62M

Profitable quarters

Profitable years

Revenue per employee

ARS 639.5M

ROA

5.33%

ROA (5Y)

6.84%

ROCE

9.01%

ROE

10.58%

ROE (5Y)

19.7%

ROIC

7.25%

ROIC (5Y)

14.92%

SBC / revenue

1.54%

Tax / revenue

3.86%

Metric

Value

EPS growth

-66.24%

EPS growth (Q)

-43.69%

EPS growth (QoQ)

-0.12%

EPS growth 10Y

11.38%

EPS growth 3Y

-2.87%

EPS growth 5Y

-7.76%

EPS growth years

FCF growth

15.48%

FCF growth 3Y

12.55%

FCF growth 5Y

-1.97%

Gross profit growth

12.07%

Gross profit growth (Q)

17.95%

Gross profit growth 3Y

7.75%

Gross profit growth 5Y

2.62%

Net income growth

-66.37%

Net income growth (Q)

-44.04%

Net income growth (QoQ)

-0.86%

Net income growth 3Y

-3.11%

Net income growth 5Y

-8.3%

Net income growth years

OCF growth

9.61%

OCF growth 10Y

13.31%

OCF growth 3Y

9.95%

OCF growth 5Y

-1.4%

Operating income growth

-5.19%

Operating income growth (Q)

-33.06%

Operating income growth 3Y

5.37%

Operating income growth 5Y

-2.23%

Revenue growth

10%

Revenue growth (Q)

14.46%

Revenue growth (QoQ)

3.34%

Revenue growth 10Y

8.82%

Revenue growth 3Y

6.47%

Revenue growth 5Y

2.65%

Revenue growth quarters

Revenue growth years

Metric

Value

Capital expenditures

ARS -3.2T

Depreciation and amortization

ARS 6.1T

EBIT

ARS 12.2T

EBITDA

ARS 18.2T

EPS

ARS 1,034.24

Financing cash flow

ARS 16.4T

Free cash flow

ARS 12T

Free cash flow minus SBC

ARS 10.9T

Gross profit

ARS 42T

Income taxes

ARS 2.8T

Investing cash flow

ARS -34.4T

Net borrowing

ARS 25.4T

Net cash flow

ARS -2.8T

Net income

ARS 7.1T

Operating cash flow minus SBC

ARS 14.1T

Operating income

ARS 12.2T

Revenue

ARS 73.5T

Stock-based compensation

ARS 1.1T

Metric

Value

Book value per share

ARS 45,040.68

Debt / EBITDA

2.65

Debt / equity

0.63

Debt / FCF

4.15

Interest coverage

7.87

Net cash (debt)

ARS -41.4T

Net cash / market cap

-15.07%

Net debt / EBITDA

2.27

Net debt / equity

0.52

Net debt / FCF

3.44

Piotroski F-Score

Shareholders' equity

ARS 78.9T

Tangible book value

ARS -2.1T

Tangible book value per share

ARS -1,185.28

Total cash

ARS 8.5T

Total debt

ARS 49.9T

Metric

Value

Asset turnover

0.48

Current ratio

1.38

Inventory turnover

2.82

Quick ratio

0.8

Working capital

ARS 10.3T

Metric

Value

Buyback yield / dilution

0.25%

Dividend growth

47.34%

Dividend growth (10Y)

76.1%

Dividend growth (3Y)

89.59%

Dividend growth (5Y)

91.48%

Dividend growth years

Dividend payment date

2026-11-16

Dividend payment years

Dividend payout frequency

Quarterly

Dividend per share

ARS 666.10

Dividend yield

1.57%

Ex-dividend date

2026-10-15

Last dividend

ARS 238.47

Payout ratio

64.27%

Shareholder yield

1.82%

Metric

Value

10Y price change

27,769.01%

10Y return CAGR

77.42%

10Y total return

30,774.38%

150-day SMA

ARS 38,296.00

15Y price change

65,773.2%

15Y return CAGR

55.78%

15Y total return

77,109.56%

1D price change

-3.55%

1M price change

3.42%

1M total return

4.02%

1W price change

0.43%

1W total return

0.43%

1Y price change

-14.5%

1Y return CAGR

-13.07%

1Y total return

-13.06%

20-day SMA

ARS 41,193.00

200-day SMA

ARS 39,350.60

20Y price change

113,870.39%

20Y return CAGR

43.46%

20Y total return

136,285.64%

3M price change

2.82%

3M total return

3.41%

3Y price change

103.56%

3Y return CAGR

28.3%

3Y total return

111.23%

50-day SMA

ARS 42,232.00

50-day SMA vs 200-day SMA

50over200

52-week high

ARS 52,000.00

52-week high date

2025-10-27

52-week low

ARS 30,380.00

52-week low date

2026-05-11

5Y price change

556.43%

5Y return CAGR

47.13%

5Y total return

589.3%

6M price change

24.09%

6M total return

25.34%

All-time high

ARS 53,525.00

All-time high date

2025-09-19

All-time low

ARS 10.55

All-time low date

2000-09-12

Average true range (ATR)

ARS 1,187.19

Average volume

2.2K

Change from 52-week high

-18.58%

Change from 52-week low

39.37%

Change from all-time high

-20.9%

Change from all-time low

401,227.01%

Change from open

-1.81%

Day's gap

-1.78%

Dollar volume

ARS 43.4M

High price

ARS 43,200.00

Low price

ARS 41,800.00

Monthly RSI

55.36

Open price

ARS 43,120.00

Position in 52-week range

38.57%

Previous close

ARS 43,900.00

Price vs 150-day SMA

10.56%

Price vs 20-day SMA

2.78%

Price vs 200-day SMA

7.6%

Price vs 50-day SMA

0.26%

Relative volume

0.47

RSI

53.93

Sharpe ratio

-0.27

Sharpe ratio (3Y)

0.86

Sharpe ratio (5Y)

1.22

Sortino ratio

-0.2

Sortino ratio (3Y)

1.45

Sortino ratio (5Y)

2.04

Volume

Weekly RSI

55.03

YTD price change

-11.39%

YTD total return

-9.89%

Metric

Value

Float

1.7B

Shares change (QoQ)

-0.29%

Shares change (YoY)

-0.25%

Shares held by insiders

0.5%

Shares held by institutions

80.99%

Short ratio

1.9 days

BCBA/ABT (BCBA/ABT)

Price

Financial snapshot

Fair-value bridge

Latest news · BCBA/ABT

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BCBA/ABT indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BCBA/ABT

Frequently asked questions

BCBA/ABT (BCBA/ABT)

Price

Financial snapshot

Fair-value bridge

Latest news · BCBA/ABT

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BCBA/ABT indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BCBA/ABT

Frequently asked questions